How many institutional investors hold ENLV?

3 tracked institutional investors disclosed a position in ENLV (ENLIVEX THERAPEUTICS LTD) in their most recent 13F filing.

Who is the largest institutional holder of ENLV?

Cathie Wood, ARK Investment Management, holds the largest disclosed position in ENLV, valued at $584,391.

Where does this ENLV ownership data come from?

SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.

ENLV — ENLIVEX THERAPEUTICS LTD

Name: ENLIVEX THERAPEUTICS LTD (ENLV) — Institutional Ownership
Creator: InvestorLens
License: https://www.sec.gov/about/website-policies

Public company

For educational research only.InvestorLens analyzes public regulatory filings (SEC EDGAR, STOCK Act PTRs) that may be delayed by 45 days or more. Information shown is historical and is not financial, legal, or tax advice, nor a recommendation or solicitation to buy or sell any security. Always do your own research.

InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.

Sourced from SEC EDGAR public filings

About ENLIVEX THERAPEUTICS LTD (ENLV)

ENLIVEX THERAPEUTICS LTD (ENLV) appears in the most recent 13F filings of 3 tracked institutional investors. The largest disclosed position is held by Cathie Wood (ARK Investment Management), valued at $584,391. Across recent filings, tracked investors recorded 1 new positions, 0 increased, 0 reduced, and 0 exited. All data sourced from SEC 13F filings.

Smart Money Consensus™

Based on recent institutional activity in ENLV

100

/100

Strong Institutional Accumulation

Added / Increased1

Reduced0

Exited0

BearishBullish

Crowded Trade Score™

How many top investors track ENLV

/100

Emerging Interest

3investors

A small number of top investors own this.

UndiscoveredCrowded

151015+

ENLV Ownership Composition

How ENLIVEX THERAPEUTICS LTD is held across tracked investor types, based on reported 13F positions.

Dominant Type

Growth Funds

91% of tracked value

Institutions

tracked investors

Total Reported

$643.8K

combined 13F value

Growth Funds90.8%
Other9.2%

Growth Funds(1)

90.8%

Other(2)

9.2%

Tracked investors reporting ENLV

Investor	Firm	Shares	Market value	% of portfolio	As of
Cathie Wood	ARK Investment Management	628.3K	$584.4K	0.00%	Mar 31, 2026
Ken Griffin	Citadel Advisors	52.1K	$48.4K	0.00%	Mar 31, 2026
Izzy Englander	Millennium Management	11.8K	$11K	0.00%	Mar 31, 2026

Cathie WoodMar 31, 2026
ARK Investment Management
Shares
628.3K
Value
$584.4K
% Portfolio
0.00%
Ken GriffinMar 31, 2026
Citadel Advisors
Shares
52.1K
Value
$48.4K
% Portfolio
0.00%
Izzy EnglanderMar 31, 2026
Millennium Management
Shares
11.8K
Value
$11K
% Portfolio
0.00%

Recent activity

Investor	Action	Δ %	Current value	Filing date
Cathie Wood	New	—	$584.4K	May 12, 2026

Cathie Wood
New
$584.4KMay 12, 2026

Frequently asked questions

How many institutional investors hold ENLV?: 3 tracked institutional investors disclosed a position in ENLV (ENLIVEX THERAPEUTICS LTD) in their most recent 13F filing.
Who is the largest institutional holder of ENLV?: Cathie Wood, ARK Investment Management, holds the largest disclosed position in ENLV, valued at $584,391.
Did institutional ownership of ENLV increase or decrease?: Across recent 13F filings, tracked investors recorded 1 new positions, 0 increased, 0 reduced, and 0 fully exited ENLV.
Where does this ENLV ownership data come from?: SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.